Changes in the gut microbiome caused by antipsychotic medications particularly risperidone have been linked to weight gain and metabolic effects
GLP-1 drugs have rapidly revolutionized the treatment of Type 2 diabetes and obesity, with promising future applications for other medical problems, including addiction, on the horizon
Utilizing this product can result in smoother, brighter, and more even-toned skin
Studies on injectable peptides show no loss of efficacy when administered at refrigerator temperature
Benefits include: Provides consistent medication coverage for 30 days Helps people who struggle with daily medication adherence due to depression, trauma, or cognitive symptoms Reduces cravings for alcohol and opioids No risk of misuse Vivitrol, its long acting injectable form, delivers a full month of protection and removes the stress of remembering daily medication
A board-certified provider then reviews the questionnaire, determines clinical eligibility for semaglutide therapy, and creates a personalized treatment plan within 24 to 48 hours
